Research Genetic test
offered by
GTR Test Accession:
Help
GTR000260116.2
Last updated in GTR: 2019-03-18
View version history
GTR000260116.2, last updated: 2019-03-18
GTR000260116.1, last updated: 2018-04-18
Last annual review date for the lab: 2024-01-10
LinkOut
At a Glance
Conditions (2):
Help
PTEN hamartoma tumor syndrome; Cowden syndrome 1
Genes (1):
Help
PTEN (10q23.31)
Study description:
Help
Please see study website: http://www.lerner.ccf.org/gmi/clinical/pten/ for eligiblity criteria and required …
Recruitment status:
Help
Currently open
Patients may not self-enroll in this study. Enrollment must be …
Methods (1):
Help
Molecular Genetics - Sequence analysis of the entire coding region: Light Scanner
Study Description
Name:
Help
The PTEN study
Protocol number:
Help
8458
Test purpose:
Help
Contribute to generalizable knowledge
Description:
Help
Please see study website: http://www.lerner.ccf.org/gmi/clinical/pten/ for eligiblity criteria and required paperwork. Analysis includes sequencing of the PTEN promoter and DGGE analysis of the coding region, exon/intron boundaries, and flanking intronic sequences. MLPA will be done for patients meeting International Cowden Consortium diagnostic criteria (see Zbuk & Eng 2007 below) or …
View more
View citations (5)
- Zbuk KM, Eng C. Cancer phenomics: RET and PTEN as illustrative models. Nat Rev Cancer. 2007;7(1):35-45. doi:10.1038/nrc2037. Epub 2006 Dec 14. PMID: 17167516.
- Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. Ni Y, et al. Am J Hum Genet. 2008;83(2):261-8. doi:10.1016/j.ajhg.2008.07.011. PMID: 18678321.
- Heald B, Mester J, Rybicki L, Orloff MS, Burke CA, Eng C. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology. 2010;139(6):1927-33. doi:10.1053/j.gastro.2010.06.061. Epub 2010 Jun 27. PMID: 20600018.
- Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome. Bennett KL, et al. JAMA. 2010;304(24):2724-31. doi:10.1001/jama.2010.1877. PMID: 21177507.
- Tan MH, Mester J, Peterson C, Yang Y, Chen JL, Rybicki LA, Milas K, Pederson H, Remzi B, Orloff MS, Eng C. A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet. 2011;88(1):42-56. doi:10.1016/j.ajhg.2010.11.013. Epub 2010 Dec 30. PMID: 21194675.
Study type:
Help
Observational study
Offered by:
Help
Person responsible for the study:
Help
Charis Eng, PhD, MD, FACP, Lab Director
Study contact:
Help
Charis Eng, PhD, MD, FACP, Lab Director
Research contact policy:
Help
Laboratory can only accept contact from health care providers. Patients/families interested in participating in a research study should discuss this option with their health care provider.
Participation
Recruitment status:
Help
Currently open
Eligibility criteria:
Help
Patients may not self-enroll in this study. Enrollment must be facilitated by a health care provider (genetic counselor, doctor, nurse, etc.) able to take responsibility for receiving the patient's results: Please be aware that an OFC (head circumference) measurement is a required data point for all study participants. You may …
View more
Consent form:
Help
Not provided
Conditions
Help
Total conditions: 2
Condition/Phenotype | Identifier |
---|
Test Targets
Genes
Help
Total genes: 1
Gene | Associated Condition | Germline or Somatic | Allele (Lab-provided) | Variant in NCBI |
---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument *
Sequence analysis of the entire coding region
Light Scanner
* Instrument: Not provided
Technical Information
Recommended fields not provided:
Test Confirmation
Additional Information
Suggested reading:
Clinical resources:
Molecular resources:
Consumer resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.